ImmunoKey
ImmunoKey is establishing an immune therapy with a mission to transform patient outcomes in solid cancers. To reach patients with urgent need, we are developing our initial therapy for ovarian cancer patients. Founding team with biotech exit, raising funds to advance towards clinical trials.
We act as an investment opportunity aggregator, collecting hundreds of investment opportunities from across the UK.
If you'd like your events, opportunities and news listed here please join free as an organisation.